Biodefense Market Global Market Report 2023: Infectious Diseases Pose Mounting Threat to Global Health, Spurring Explosive Growth
May 18, 2023 06:03 ET
|
Research and Markets
Dublin, May 18, 2023 (GLOBE NEWSWIRE) -- The "Biodefense Market - Global Industry Analysis (2019 - 2022), Growth Trends, and Market Forecast (2023 - 2030)" report has been added to ...
Anthrax Treatment Market to Exhibit a Remarkable CAGR of 6.6% by 2029, Size, Share, Trends, Rising Demand, Market Dynamics and Opportunity Analysis
February 15, 2023 14:30 ET
|
Data Bridge Market Research
OTTAWA, Feb. 15, 2023 (GLOBE NEWSWIRE) -- A recent study report released by Data Bridge Market research titled “Anthrax Treatment Market” (covering USA, Europe, China, Japan, India, South East Asia...
Biodefense Industry Trends and Opportunities 2021-2025 - Insights Into Anthrax, Smallpox, Botulism, and Other Applications
February 07, 2022 05:03 ET
|
Research and Markets
Dublin, Feb. 07, 2022 (GLOBE NEWSWIRE) -- The "Global Biodefense Market 2021-2025" report has been added to ResearchAndMarkets.com's offering. The global biodefense market is projected to grow by...
Global Biodefense Market to Surpass US$ 17.0 Billion by 2028; Increasing efforts to stockpile vaccines to drive the Market Growth, Says Coherent Market Insights (CMI)
July 15, 2021 09:05 ET
|
CMI
SEATTLE, July 15, 2021 (GLOBE NEWSWIRE) -- According to Coherent Market Insights, the global biodefense market is estimated to be valued at US$ 12.2 billion in 2021 and is expected to exhibit a CAGR...
Biodefense Market value to surpass $19 Billion by 2024: Global Market Insights, Inc.
January 30, 2019 04:09 ET
|
Global Market Insights, Inc
Sellbyville, Delaware, Jan. 30, 2019 (GLOBE NEWSWIRE) -- Canada biodefense market was valued at USD 349.3 million in 2017 and is expected to have considerable revenue size during the forecast...
Biodefense Market size worth USD 17 billion by 2024, with 6.9% CAGR estimation from 2016 to 2024: Global Market Insights Inc.
August 12, 2016 10:00 ET
|
Global Market Insights
Ocean View, Delaware, Aug. 12, 2016 (GLOBE NEWSWIRE) -- Biodefense Market size forecast predicts over USD 17 billion in revenue by 2024; according to the latest research report by Global...
Smithsonian and VariGuard Presenting at Washington Conservation Guild's Event: "Outsmarting Light: SmartGlass Technology in Exhibitions"
November 05, 2014 16:24 ET
|
Research Frontiers Inc.
WASHINGTON, DC--(Marketwired - November 05, 2014) - Museums can now show the public light-sensitive documents and other artifacts that otherwise literally might not see the light of day. Dr. Seth Van...
Ten Years After Anthrax Attacks, Public Health Laboratory System Eroding due to Funding Cuts
October 04, 2011 08:51 ET
|
Association of Public Health Laboratories (APHL)
SILVER SPRING, MD--(Marketwire - Oct 4, 2011) - On the tenth anniversary of the anthrax attacks that followed 9/11, the US laboratory network that tested over 125,000 samples for the deadly...
PositiveID Corporation Announces the Launch of its Multiplex BioThreat Assay, the First Commercially Available Product of its Kind
June 21, 2011 08:30 ET
|
PositiveID Corporation
DELRAY BEACH, Fla., June 21, 2011 (GLOBE NEWSWIRE) -- PositiveID Corporation ("PositiveID" or "Company") (Nasdaq:PSID), a developer of medical technologies for diabetes management, clinical...
Human Genome Sciences Begins Delivery of First-in-Class Anthrax Treatment to U.S. Strategic National Stockpile
February 02, 2009 07:00 ET
|
Human Genome Sciences, Inc.
ROCKVILLE, MD--(Marketwire - February 2, 2009) - Human Genome Sciences,
Inc. (NASDAQ: HGSI) today announced that it has begun delivery of
20,000 doses of its human monoclonal antibody drug...